Cordis ANGIOGRAPHIC CATHETERIZATION SETS, INFINITI THRULEMEN, 5F, REF CO0208, cardiac catheter

FDA Device Recall #Z-0286-2024 — Class I — September 26, 2023

Recall Summary

Recall Number Z-0286-2024
Classification Class I — Serious risk
Date Initiated September 26, 2023
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Cordis US Corp
Location Miami Lakes, FL
Product Type Devices
Quantity 30 devices

Product Description

Cordis ANGIOGRAPHIC CATHETERIZATION SETS, INFINITI THRULEMEN, 5F, REF CO0208, cardiac catheter

Reason for Recall

Non-sterile product labeled as sterile was distributed.

Distribution Pattern

US Distribution to: OK

Lot / Code Information

UDI/DI 10705032025935, Lot Number 18223410

Other Recalls from Cordis US Corp

Recall # Classification Product Date
Z-1511-2025 Class II Cordis, REF: C09060ML, Smart Control Vascular S... Mar 4, 2025
Z-1510-2025 Class II Cordis, REF C10040ML, Smart Control Vascular St... Mar 4, 2025
Z-1330-2025 Class II Vista Brite Tip, Judkins Right 4, REF SM7504, J... Feb 7, 2025
Z-0675-2024 Class II MYNXGRIP 6F/7F, REF MX6721, Vascular Closure De... Nov 28, 2023
Z-0674-2024 Class II MYNXGRIP 5F, REF MX5021, Vascular Closure Devic... Nov 28, 2023

Frequently Asked Questions

Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.